Jindal Steel & Power becomes regular supplier of Indian Railways; stock gains 59.83 in a year
Jindal Steel & Power becomes regular supplier of Indian Railways; stock gains 59.83 in a year

Jindal Steel & Power becomes regular supplier of Indian Railways; stock gains 59.83 in a year

Deepti Shidore Article rating: 5.0

Jindal Steel & Power Limited (JSPL) is a conglomerate operating in the steel, power, mining & infrastructure sector. The company has become the first-ever private company to get the stamp of ‘regular supplier’ from the Indian railways. JSPL would be supplying 60 kg of 880-grade prime (90 UTS) rails, which has been approved by Research Design & Standards Organisation (RDSO) as well as by the Ministry of Railways.   

eClerx announces acquisition of Personiv; stock gains by nearly 22 per cent in a month
eClerx announces acquisition of Personiv; stock gains by nearly 22 per cent in a month

eClerx announces acquisition of Personiv; stock gains by nearly 22 per cent in a month

Deepti Shidore Article rating: 3.6

eClerx Services announced that it is acquiring Eclipse Global Holdings LLC (Personiv), which is an Austin, Texas-headquartered company having its operations in business process management & services, with a special focus on the outsourced accounting space.  

Stocks that are likely to record significant movement on bourses today
Stocks that are likely to record significant movement on bourses today

Stocks that are likely to record significant movement on bourses today

Deepti Shidore Article rating: 2.1

Market on Wednesday ended in the green, overshadowing the global sentiment due to a new strain of COVID-19 found in the UK. Sensex went up by 0.95 per cent, a hike of 437.49 points, and settled at 46,444.18. Nifty too gained, 134.8 points, a 1 per cent gain at 13,601.10. It proved to be a good day for IT stocks with Infosys being one of the top gainers, followed by Hindustan Unilever and Mahindra & Mahindra.  

Birlasoft beating reds; up by 200 per cent in 2020
Birlasoft beating reds; up by 200 per cent in 2020

Birlasoft beating reds; up by 200 per cent in 2020

Deepti Shidore Article rating: 3.8

Birlasoft has multiple verticals including energy, manufacturing, banking, financial services & insurance (BFSI). The company also provides digital transformation and integrated solutions to enterprises. The contribution from these verticals is divided and is not dependent on one particular industry thereby, making it a diversified portfolio.

M&M plunges nearly 3 per cent post announcing price hike of tractors
M&M plunges nearly 3 per cent post announcing price hike of tractors

M&M plunges nearly 3 per cent post announcing price hike of tractors

Deepti Shidore Article rating: 5.0

Taking into consideration the increasing commodity prices, Mahindra & Mahindra (M&M) announced on Monday that it is planning to increase the prices of its tractors. Reacting to this, the stock of M&M soon slumped nearly 3 per cent on BSE. 

Page Industries gets WRAP recertification; surges more than 9 per cent
Page Industries gets WRAP recertification; surges more than 9 per cent

Page Industries gets WRAP recertification; surges more than 9 per cent

Deepti Shidore Article rating: 3.8

Page Industries has an exclusive licence of Jockey International Inc. for manufacturing, distribution & marketing its products in India, Bangladesh, Omar, Qatar, Sri Lanka, Nepal, Maldives, Bhutan, and UAE as well as of Speedo International Ltd but only in India. 

Cipla rises more than 4 per cent after settling over cancer drug Revlimid; earnings likely to boost
Cipla rises more than 4 per cent after settling over cancer drug Revlimid; earnings likely to boost

Cipla rises more than 4 per cent after settling over cancer drug Revlimid; earnings likely to boost

Deepti Shidore Article rating: 4.0

Cipla has settled its patent litigation with Celgene over the blockbuster cancer drug Revlimid. Celgene Corporation, a subsidiary of Bristol Myers Squibb, has agreed to provide Cipla with a licence to Celgene’s required patents. Cipla can then sell or manufacture certain volume-limited amounts of generic Lenalidomide in the United States sometime after March 2022.

DSIJ MINDSHARE

Mkt Commentary23-Apr, 2024

Multibaggers23-Apr, 2024

Quarterly Results23-Apr, 2024

Multibaggers23-Apr, 2024

Mindshare23-Apr, 2024

Knowledge

Fundamental21-Apr, 2024

General21-Apr, 2024

Technical19-Apr, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR